Meth A fibrosarcoma cells express two transforming mutant p53 species
- PMID: 3060794
Meth A fibrosarcoma cells express two transforming mutant p53 species
Abstract
Expression plasmids directing the synthesis of various forms of the p53 cellular tumor antigen were compared with respect to their biological activities. All plasmids encoding wild type p53, derived from two different cDNA libraries, had absolutely no detectable activity when assayed for transformation of primary rat embryo fibroblasts in collaboration with Ha-ras. In contrast, p53 variants carrying point mutations in the protein coding region exhibited at least some transforming activity. Most notably, this was true for both types of mutant p53 cDNA clones isolated from Meth A cells. The data indicate that these cells, derived from a chemically-induced tumor, carry two independently mutated p53 alleles, each encoding a transformationally activated protein. This may imply that the mutations in the p53 gene played a role in the development of the Meth A tumor. Finally, cells overexpressing a transfected mutant p53 exhibit a physical complex between this exogenous p53 and its endogenous counterpart, possibly resulting in the stabilization of the latter.
Similar articles
-
Immortalization of rat embryo fibroblasts by the cellular p53 oncogene.Oncogene. 1988 May;2(5):445-52. Oncogene. 1988. PMID: 3287278
-
Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.Cell Growth Differ. 1990 Dec;1(12):571-80. Cell Growth Differ. 1990. PMID: 2288874
-
Malignant transformation of rat embryo fibroblasts by cotransfection with eleven human mutant p53 cDNAs and activated H-ras gene.Oncogene. 1995 Oct 5;11(7):1339-45. Oncogene. 1995. PMID: 7478555
-
The p53 cellular tumor antigen: gene structure, expression and protein properties.Biochim Biophys Acta. 1985 Nov 12;823(1):67-78. doi: 10.1016/0304-419x(85)90015-0. Biochim Biophys Acta. 1985. PMID: 3902087 Review. No abstract available.
-
A comparison of the properties of human p53 mutant alleles.Adv Exp Med Biol. 1993;330:55-65. doi: 10.1007/978-1-4615-2926-2_5. Adv Exp Med Biol. 1993. PMID: 8368143 Review. No abstract available.
Cited by
-
Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.J Clin Invest. 1992 Feb;89(2):640-7. doi: 10.1172/JCI115630. J Clin Invest. 1992. PMID: 1737852 Free PMC article.
-
Isolation and characterization of DNA sequences that are specifically bound by wild-type p53 protein.Mol Cell Biol. 1993 Mar;13(3):1378-84. doi: 10.1128/mcb.13.3.1378-1384.1993. Mol Cell Biol. 1993. PMID: 8441383 Free PMC article.
-
Species-specific phosphorylation of mouse and rat p53 in simian virus 40-transformed cells.J Virol. 1992 Jun;66(6):3846-59. doi: 10.1128/JVI.66.6.3846-3859.1992. J Virol. 1992. PMID: 1316485 Free PMC article.
-
Tumor suppressor p53: analysis of wild-type and mutant p53 complexes.Mol Cell Biol. 1991 Jan;11(1):12-9. doi: 10.1128/mcb.11.1.12-19.1991. Mol Cell Biol. 1991. PMID: 1986215 Free PMC article.
-
Mutations in p53 do not account for heritable breast cancer: a study in five affected families.Br J Cancer. 1991 Feb;63(2):181-4. doi: 10.1038/bjc.1991.44. Br J Cancer. 1991. PMID: 1997094 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous